Engineering the E. coli UDP‐Glucose Synthesis Pathway for Oligosaccharide Synthesis

A metabolic engineering strategy was successfully applied to engineer the UDP‐glucose synthesis pathway in E. coli. Two key enzymes of the pathway, phosphoglucomutase and UDP‐glucose pyrophosphorylase, were overexpressed to increase the carbon flux toward UDP‐glucose synthesis. When additional enzymes (a UDP‐galactose epimerase and a galactosyltransferease) were introduced to the engineered strain, the increased flux to UDP‐glucose synthesis led to an enhanced UDP‐galactose derived disaccharide synthesis. Specifically, close to 20 mM UDP‐galactose derived disaccharides were synthesized in the engineered strain, whereas in the control strain only 2.5 mM products were obtained, indicating that the metabolic engineering strategy was successful in channeling carbon flux (8‐fold more) into the UDP‐glucose synthesis pathway. UDP‐sugar synthesis and oligosaccharide synthesis were shown to increase according to the enzyme expression levels when inducer concentration was between 0 and 0.5 mM. However, this dependence on the enzyme expression stopped when expression level was further increased (IPTG concentration was increased from 0.5 to 1 mM), indicating that other factors emerged as bottlenecks of the synthesis. Several likely bottlenecks and possible engineering strategies to further improve the synthesis are discussed.

[1]  N. Kleckner,et al.  Molecular cloning and characterization of the pgm gene encoding phosphoglucomutase of Escherichia coli , 1994, Journal of bacteriology.

[2]  T. Saito,et al.  Purification of glutathione S-transferase fusion proteins as a non-degraded form by using a protease-negative E. coli strain, AD202. , 1994, Nucleic acids research.

[3]  Rachel Chen,et al.  A pH-sensitive assay for galactosyltransferase. , 2004, Analytical biochemistry.

[4]  B. Priem,et al.  A new fermentation process allows large-scale production of human milk oligosaccharides by metabolically engineered bacteria. , 2002, Glycobiology.

[5]  C. Balch,et al.  A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). , 1981, Journal of immunology.

[6]  J Thiem Applications of enzymes in synthetic carbohydrate chemistry. , 1995, FEMS microbiology reviews.

[7]  E. Agosin,et al.  Impact of Heterologous Expression of Escherichia coli UDP-Glucose Pyrophosphorylase on Trehalose and Glycogen Synthesis in Corynebacterium glutamicum , 2004, Applied and Environmental Microbiology.

[8]  A. Ozaki,et al.  Large-scale production of CMP-NeuAc and sialylated oligosaccharides through bacterial coupling , 2000, Applied Microbiology and Biotechnology.

[9]  Chi‐Huey Wong,et al.  Complex carbohydrate synthesis tools for glycobiologists: enzyme-based approach and programmable one-pot strategies. , 2000, Glycobiology.

[10]  E. P. Kennedy,et al.  UTP: alpha-D-glucose-1-phosphate uridylyltransferase of Escherichia coli: isolation and DNA sequence of the galU gene and purification of the enzyme , 1994, Journal of bacteriology.

[11]  P. Wang,et al.  Enhanced Production of α-Galactosyl Epitopes by Metabolically Engineered Pichia pastoris , 2003, Applied and Environmental Microbiology.

[12]  S. Cottaz,et al.  Genetic engineering of Escherichia coli for the production of NI,NII-diacetylchitobiose (chitinbiose) and its utilization as a primer for the synthesis of complex carbohydrates. , 2005, Metabolic engineering.

[13]  P. Frey,et al.  The isolation, purification, and preliminary crystallographic characterization of udp‐galactose‐4‐epimerase from Escherichia coli , 1991, Proteins.

[14]  P. Wang,et al.  Production of α‐Galactosyl Epitopes via Combined Use of Two Recombinant Whole Cells Harboring UDP‐Galactose 4‐Epimerase and α‐1,3‐Galactosyltransferase , 2000 .

[15]  A. Imberty,et al.  The living factory: In vivo Production of N-acetyllactosamine containing carbohydrates in E. coli , 1999, Glycoconjugate Journal.

[16]  B. Priem,et al.  Large‐Scale In Vivo Synthesis of the Carbohydrate Moieties of Gangliosides GM1 and GM2 by Metabolically Engineered Escherichia coli , 2003, ChemBioChem.

[17]  Tetsuo Endo,et al.  Large-scale production of UDP-galactose and globotriose by coupling metabolically engineered bacteria , 1998, Nature Biotechnology.

[18]  W. Wakarchuk,et al.  Efficient preparation of natural and synthetic galactosides with a recombinant beta-1,4-galactosyltransferase-/UDP-4'-gal epimerase fusion protein. , 2001, The Journal of organic chemistry.

[19]  E. Samain,et al.  Production of O-acetylated and sulfated chitooligosaccharides by recombinant Escherichia coli strains harboring different combinations of nod genes. , 1999, Journal of biotechnology.

[20]  M. Blaser,et al.  Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between h. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. , 1998, The Journal of biological chemistry.

[21]  W. Wakarchuk,et al.  Role of paired basic residues in the expression of active recombinant galactosyltransferases from the bacterial pathogen Neisseria meningitidis. , 1998, Protein engineering.

[22]  C. Yanisch-Perron,et al.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. , 1985, Gene.

[23]  J Alper,et al.  Searching for Medicine's Sweet Spot , 2001, Science.